Balance Sheet for Rigel Pharmaceuticals Inc. (RIGL)

$ 2.46   -0.01 (-0.40%) Volume: 1.92m 3:26 PM EDT Oct 28, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 22,521 76,322 38,290 17,632 43,456
Restrictable Cash - - - - -
Marketable Securities 75,557 52,215 77,461 57,134 82,820
Accounts Receivable 10,111 4,077 - - 203
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 10,111 4,077 - - 203
Inventories, Raw Materials - - - - -
Inventories, Work in Progress 810 530 - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 544 364 - - -
Inventories, Other 1,354 894 - - -
Inventories, Adjustments & Allowances - - - - -
Inventories 1,354 894 - - -
Prepaid Expenses 9,462 3,479 1,682 1,448 2,545
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 119,005 136,987 117,433 76,214 129,024
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment 14,640 14,241 13,153 19,948 19,763
Construction in Progress 564 - - - -
Fixed Assets, Other 25,709 - - - -
Fixed Assets, Total 40,913 14,241 13,153 19,948 19,763
Gross Fixed Assets 40,913 14,241 13,153 19,948 19,763
Accumulated Depreciation (13,045) (12,854) (12,278) (18,792) (18,150)
Net Fixed Assets 27,868 1,387 875 1,156 1,613
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 696 735 803 764 1,110
Total Non-Current Assets 28,564 2,122 1,678 1,920 2,723
Total Assets 147,569 139,109 119,111 78,134 131,747
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 4,152 6,391 2,636 5,563 2,763
Short Term Debt 7,272 - - - -
Notes Payable - - - - -
Accrued Expenses 12,681 10,361 8,358 6,914 6,086
Accrued Liabilities 12,681 10,361 8,358 6,914 6,086
Deferred Revenues 25,288 1,030 - - 13,427
Current Deferred Income Taxes - - - - -
Other Current Liabilities 8,819 9,952 7,343 10,111 11,520
Total Current Liabilities 58,212 27,734 18,337 22,588 33,796
Long Term Debt 9,810 N/A N/A - -
Deferred Income Tax 1,404 1,498 90 517 6,543
Other Non-Current Liabilities 6,502 1,498 128 519 6,570
Minority Interest - - - - -
Capital Lease Obligations 19,230 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 35,542 1,498 128 519 6,570
Total Liabilities 93,754 29,232 18,465 23,107 40,366
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 53,815 109,877 100,646 55,027 91,381
Common Par 168 167 147 100 91
Additional Paid in Capital 1,329,852 1,319,068 1,239,435 1,115,807 1,082,980
Cumulative Translation Adjustments - - - - -
Retained Earnings (1,276,228) (1,209,334) (1,138,854) (1,060,862) (991,646)
Treasury Stock - - - - -
Other Equity Adjustments 23 (24) (82) (18) (44)
Total Capitalization 63,625 109,877 100,646 55,027 91,381
Total Equity 53,815 109,877 100,646 55,027 91,381
Total Liabilities & Shareholder's Equity 147,569 139,109 119,111 78,134 131,747
Cash Flow (66,504) (70,308) (78,107) (70,272) (51,464)
Working Capital 60,793 109,253 99,096 53,626 95,228
Free Cash Flow (42,965) (59,932) (77,721) (76,693) (23,959)
Invested Capital 63,625 109,877 100,646 55,027 91,381
Shares Outstanding - Common Class Only 167,988 167,172 146,815 99,269 90,555
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 167,988 167,172 146,815 99,269 90,555
Total Common Shares Outstanding 167,988 167,172 146,815 99,269 90,555
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 167,400 160,529 126,324 94,387 88,434
Diluted Weighted Shares Outstanding 167,400 160,529 126,324 94,387 88,434